Maternal magnesium sulfate administration increases early-onset hyperkalemia risk in premature infants: A propensity score-matched, case-control study
Background: Magnesium sulfate (MgSO4) is a common substance administered to pregnant women with preeclampsia or eclampsia to prevent and treat seizures or gestational hypertension. This study aimed to evaluate whether administering maternal magnesium sulfate increased the risk of early-onset hyperka...
Saved in:
Main Authors: | Sayu Omori-Shimano (Author), Takahiro Tominaga (Author), Kazushige Ikeda (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of premature rupture of membranes on clinical outcomes of extremely premature infants: A propensity score matching study
by: Jing-Ke Cao, et al.
Published: (2023) -
Understanding the effect of loneliness on unemployment: propensity score matching
by: N Morrish, et al.
Published: (2022) -
POSSIBILITY OF APPLICATION OF MAGNESIUM SULFATE AS A NEUROPROTECTOR IN THE DEVELOPMENT OF PREMATURE BIRTH
by: I. O. Makarov, et al.
Published: (2016) -
Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
by: Hye-Ran Jun, et al.
Published: (2021) -
Total and ionized serum magnesium and calcium levels during magnesium sulfate administration for preterm labor
by: Won Hee Kim, et al.
Published: (2018)